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The appropriateness of the initial response and countermeasures taken following the Fukushima
nuclear power plant accident after the Great East Japan Earthquake on March 11, 2011 should be
further examined. Implementation of a prospective epidemiological study on human health risks
from low-dose radiation exposure and comprehensive health protection from radiation should be
emphasized on a basis of the lessons learnt from the Chernobyl nuclear power plant accident. In
contrast, the doses to a vast majority of the population in Fukushima were not high enough to
expect to see any increase in incidence of cancer and health effects in the future, however, public
concerns about the long-term health effects of radioactive environmental contamination have
increased in Japan. Since May 2011, the Fukushima Prefecture started the Fukushima Health
Management Survey Project with the purpose of long-term health care administration and early
medical diagnosis/treatment for prefectural residents. In this report, risk and countermeasures of
thyroid cancer occurrence after nuclear accidents, especially due to early exposure of radioactive
iodine, will be focused upon to understand the current situation of risk of thyroid cancer in
Fukushima, and the difﬁcult challenges surrounding accurate estimations of low-dose and low-
dose rate radiation exposures will be discussed.
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The worst nuclear power plant accident in Japan occurred just
after the Great East Japan Earthquake on March 11, 2011. The
scientiﬁc understanding about the relationship between radia-
tion exposure dose and health risks continues to be indispen-
sable for proper emergency correspondence immediately after
nuclear power plant accidents. According to accumulated data
from survivors of the atomic bomb analyzed by the Radiation
Effects Research Foundation [1], risks of leukemia and solid
cancers occur in a dose-response manner [2,3]. Among human
cancer occurrences associated with radiation, thyroid cancer risk
increases not only after external exposure, but also after internal
exposure to radioactive iodine, as epidemiologically clariﬁed just
after the Chernobyl accident [4–6]. Both factors are especially
important to understand the health effects of radiation exposure,
and a standardized measure of radiation dosage known as the
Sievert unit (Sv) should be utilized. Measurements using the Sv
unit have indicated that health effects between external and
internal exposure are theoretically the same from the standpoint
of biological effects.
Although by International Standard, the Fukushima nuclear
power plant accident was estimated as a level 7 accident that
caused massive environmental radioactive contamination
equivalent to the Chernobyl accident, the actual condition and
damage scales differ greatly. Thyroid blocking with suitable
medication like a stable iodine tablet should be prepared for the
reduction and prevention of any internal exposure to radioactive
iodine immediately after an accident [7]. Moreover, the safety of
food should be strictly controlled by discarding polluted milk and
other food items after large-scale accidents. Although the side
effects and effectiveness of iodine tablet dosage needs to be
veriﬁed [8], ample room remains for the development and
practical improvement of campaigns toward iodine thyroid block-
ing in Japan. More speciﬁcally, evaluation of the dose of radio-
activity is of utmost importance, and longitudinal epidemiologic
surveys, such as improvement to the regional cancer registration
system and mortality surveys, would be indispensable to our
precise understanding of radiation-associated cancer risk. Since
thyroid cancer risk principally occurs due to a stochastic effect,
and simultaneous comprehensive health risk management and
risk communication are necessary for the public. In addition, an
understanding of the basics of the molecular mechanisms under-
lying thyroid biology and carcinogenesis is also required [9].
This report outlines the nuclear accident at Fukushima
and summarizes thyroid cancer risk, assuming the possibility
of initial exposure to radioactive iodine and drawing lessons
from the Chernobyl nuclear accident.2. Chernobyl accident and thyroid cancer risk
On the early morning of April 26, 1986, an explosion occurred
in the Chernobyl Nuclear Power Unit No. 4 High PowerChannel-type Reactor, a water-cooled, graphite-moderated
nuclear power reactor designed in the former Soviet Union
(existing Ukraine). The nuclear reactor and the building that
housed the reactor were destroyed by the accident. Subse-
quently, a ﬁre broke out and spread rapidly due to scattering of
hot black lead. Large-scale radioactive material was released into
the environment until May 6, 1986. The main radioactive
materials emitted were iodine-131, cesium-134, cesium-137,
niobium-95, cerium-144, ruthenium-103, ruthenium-106, stron-
tium-90, plutonium-239, and plutonium-240, which reached a
total amount of 14 exabecquerel. An exabecquerel is a unit
representing 1000 quadrillion times (1018). Although large parti-
cles of strontium and plutonium descended in an area less than
100 km from the nuclear plant, other radioactive materials were
widely diffused in the Northern Hemisphere around Europe [10].
Immediately after the accident, external exposure became a
problem for workers inside the nuclear power plant or in nearby
high-dose areas, whereas internal exposure became a problem
for nearby residents exposed indirectly to radioactive fallout.
In particular, iodine-131 contamination was found in milk
derived from pastured cows that fed on iodine-131-contaminated
grass from the surrounding Chernobyl area; this was a critical
problem for the local residents. Due to insufﬁcient restriction of
the distribution and ingestion of the iodine-131-contaminated
milk by the government, people continued to consume the
contaminated milk, particularly children from Belarus, Russia,
and the Ukraine of the former USSR during the Cold War era.
Chernobyl is an inland area that previously lacked iodine con-
tamination. When ingested, the thyroid gland selectively takes in
iodine, including iodine-131. Therefore, milk contaminated with
iodine-131 was the contributing factor that exacerbated internal
exposure to the thyroid glands of children who ingested the
contaminatedmilk. These childrenwere exposed to an estimated
dozen to several thousand millisievert dose of radiation to their
thyroid gland. As a result, it has been reported that infant thyroid
cancer (papillary adenocarcinoma) increased rapidly in children,
especially those aged 0–5 years at the time of the accident [11].
The case-control study supports a positive relationship between
childhood thyroid cancer occurrence and thyroidal iodine-131
exposure [12]. The dose threshold of radiation-associated thyroid
cancer in childhood has not been scientiﬁcally clariﬁed, and no
consensus exists on the threshold according to the hypothesis of
the linear non-threshold (LNT) model [13]. However, some
reports using theoretical models from Chernobyl, such as the
LNT model, suggest that the critical internal thyroid exposure
doses are conservatively more than 50–200mSv in children [4–6].
Thyroid dose re-evaluation poses many difﬁculties; however, a
comparative study on children who were born before
and after the Chernobyl accident supports the etiological role of
short half-life radioactive iodine on childhood thyroid cancer,
despite a lack of direct measurements of the dose of thyroid
exposure [14].
The number of thyroid cancers cases continues to increase,
even 25 years after the accident [15], and has amounted to
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infant thyroid cancer has shifted to adulthood. The detailed
molecular mechanism of thyroid carcinogenesis is still being
examined, but signature genes associated with radiation expo-
sure have not been identiﬁed [17]. However, high-frequency
gene polymorphisms (SNPs) have been found in European
populations surrounding Chernobyl [18], and these SNPs were
found to be largely, although not fully, overlapping with the
original SNPs that are related with cancer risk, according to
studies that determined disease-susceptibility genes in thyroid
cancer patients [19].
Iodine-131 decays quickly with a half-life of approximately
8 days; however, radioactive cesium remains in the environ-
ment much longer. The physical half-life of cesium-134 and
cesium-137 is 2 years and 30 years, respectively. Radioactive
cesium can contaminate many animals and plants through
pollution of the food chain. High-level cesium-137 was
detected in mushrooms, grapes, and meat 20 years after the
Chernobyl accident, and internal exposure through ingestion
continues in parts of Belarus, the Ukraine and Russia [20].
As per a report on Chernobyl published as a joint forum by
the International Atomic Energy Agency (IAEA), the World
Health Organization (WHO), and others, 20 years after the
accident, only infant thyroid cancer was accepted as a
consequence of radiation after the accident, while other
malignant tumors and changes to the body resulting from
cesium including leukemia and other solid cancers were not
accepted [21]. Moreover, no difference was seen in the rate of
congenital abnormality between cesium-contaminated areas
and non-contaminated areas. In the joint forum, it was
speciﬁed that the greatest health problems after a large
accident are mental and psychosocial consequences.3. Radiation dose estimation after the
Fukushima nuclear power plant accident
All nuclear reactors at the ﬁrst and second TEPCO-Nuclear
Power Plants in Fukushima stopped automatically after the
Great East Japan Earthquake on March 11, 2011. Continuous
cooling is needed for nuclear fuel and spent nuclear fuel in a
nuclear reactor or a spent nuclear fuel pool for the decay to
remove the heat generated; however, all power supplies to
reactors nos. 1–4 for cooling were lost due to the earthquake,
tsunami, hydrogen explosion, and other disasters that
occurred in succession. As a result, a lot of radioactive
material was emitted to the outside environment and spread
through the wind. Besides the nuclear power plant workers
and surrounding residents who intervened within a 20 km
radius of the accident, almost all residents near the nuclear
power plant took refuge at least 2–3 km away by March 11,
then moved 10 km away, and ﬁnally moved 20 km away
according to the resident evacuation order on March 12.
Within 48 h, approximately 77,000 local residents ﬂed from
the 20 km zone and later, many people evacuated from all
restricted areas.
Although body surface screening for the evacuees of the
Fukushima Prefecture started on March 13, the cutoff value
for whole body decontamination at the screening level was
up to 100,000 cpm, using the GM survey meter (diameter of5 cm) on and after March 15. Radioactive material spread
from the nuclear power plant to the northwest through the
southeastern wind on the afternoon of March 15, and a high
spatial dose rate of approximately 20 mSv/h was observed in
Fukushima city, about 60 km from the nuclear power plant.
According to the environmental data measured in Fukush-
ima, radioactive material dispersed through the wind after
the hydrogen explosion occurred at the nuclear power plant
and contaminated all surfaces. The main radioactive nuclide
emitted from the nuclear power plant was iodine-131.
According to measurements of the area using a high spatial
dose rate, an immediate declining trend of iodine-131 in the
environment was observed. Other radioactive nuclides
emitted from the nuclear power plant included cesium-134
and cesium-137, which have a long physical half-life and thus
deposit in soil, on roofs, on outer walls of a buildings, and
other surfaces for a long time.
Restrictions on shipments and the sales of food containing
radioactive iodine and cesium began with milk from the
Fukushima Prefecture and spinach from the Fukushima,
Ibaraki, and Tochigi Prefectures on March 21. The safe
interim standard level for food was set at a maximum annual
internal exposure dose of 5 mSv at the end of March following
the accident, and shipment restrictions and restrictions on
food exceeding this value were implemented. As of April
2012, the annual internal exposure dose became stricter at
1 mSv following the stabilization of the nuclear power plant.
Unfortunately, the calculation and prediction of the con-
centration of radioactive materials in the air, the radioactive
dose, and other measurements immediately after the acci-
dent could not be performed due to insufﬁcient information
on the source of emission, which was based on the weather
survey data, radiation data, wind velocity and System for
Prediction of Environmental Emergency Dose Information
(SPEEDI). The members of the Radiation Medical Assistance
Team dispatched from Nagasaki University stayed in Fukush-
ima from 16:00 on March 14 to 17:00 on March 19 to observe
and announce the spatial dose rate of Fukushima and the
calculated dose of radioactivity. These levels were predicted
to be 1354 mSv, but the integrated value read from personal
dosimeters was 42–62 mSv over 4 days. Most measurements
were taken indoors, while the spatial dose rate was measured
at a height of 1 m from the ground outside. In many cases,
the actual external exposure dose was relatively low because
buildings shielded radiation levels. However, further veriﬁca-
tion from local residents and evacuees from Fukushima is
required, and it is important to utilize these individual
effective dose data for appropriate action in the case of future
accidents.
Estimations of external radiation exposure doses for peo-
ple residing in Fukushima at the time of the earthquake were
conducted as a basic investigation under a prefectural health
management survey by the Fukushima Prefecture [22]. The
study protocol for this survey has been detailed elsewhere
[23]. Data from an original basic survey targeting residents of
the evacuation prepared zone were collected from a preli-
minary investigation conducted over 4 months until July 11,
2011. The maximum estimated external exposure levels of
9747 people (excluding the radiation operation workers) of
Kawamata-cho (Yamakiya area), Namie-cho, and Iitate-mura
r e s p i r a t o r y i n v e s t i g a t i o n 5 1 ( 2 0 1 3 ) 1 2 8 – 1 3 3 131were found to be 23 mSv. Thus, 94.6% were exposed to doses
ofo5 mSv per year, and, if including those that were exposed
to doses of o10 mSv, 99.3% of the population were exposed.
The most recent data released from the Fukushima Prefec-
ture on December 2012 indicated that the average dose of
more than 300,000 residents was o1 mSv. The Health Man-
agement Survey Committee of Fukushima examined these
results and stated, “it is difﬁcult to consider the level of
health impairments caused by radiation,” but the manage-
ment of health and efforts toward the reduction of future
radiation exposure, such as decontamination and avoidance
of contaminated foods, are continuously required.
Children in Iitate-mura and Iwaki Prefecture have been
hypothesized to have thyroid radiation exposure possibly
reaching 100 mSv by SPEEDI, although they were residing
outside the 20 km range. According to a report by Hirosaki
University [24], levels of radiation subjected to the thyroid
gland may have reached 10 mSv in infants who stayed within
20 km at the time of the accident, and prospective observa-
tion of these infants is required. Furthermore, direct mea-
surements of internal exposure soon after the accident
suggest a low possibility of any stochastic health effects [25].
The WHO released estimated results of exposure levels
around Fukushima in May 2012. Using SPEEDI, prediction
data were calculated conservatively from a viewpoint of
protection, assuming that the residents did not take refuge
for 4 months after the accident in the prepared evacuation
area of the nuclear power plant and did not limit their
consumption to that of restricted food [26]. According to
these assumptions, a 1-year-old child's thyroid radiation dose
would be 10–100 mSv in Minami-soma, Iwaki, and Iitate-
mura, the prepared evacuation areas, and 1–10 mSv in the
prefectures adjacent to Fukushima. However, these data
largely deviate from the actual values calculated by thyroid
screening and examination using the Whole Body Counter
test mentioned above. Further, it is necessary to promote
cooperation with international organizations and come to a
consensus on accurate dose estimations based on these
acutual data.
3.1. Thyroid ultrasound examination in Fukushima
Basic investigation of dose estimations in Fukushima including
the following measures have begun: (1) thyroid ultrasound, (2)
health checkup, (3) mental health performance and lifestyle
examination, and (4) examination of expecting and nursing
mothers. The progress of these measures are uploaded onto
the homepage of the Fukushima Medical University [27]. Results
of the environmental radiation dose and investigation into
thyroidal radiation exposure dose indicated that there were very
few health effects, and these effects were considered restrictive.
However, on the basis of a rise in thyroid cancer risk in those
exposed to radiation through radioactive iodine ingestion during
childhood in Chernobyl, thyroid ultrasound examination was
conducted from October 2011 for approximately 360,000 people
aged ≤18 years. Initial thyroid ultrasound examination of
approximately 38,000 people among 48,000 candidates (approxi-
mately 80%) of the preparatory evacuation zone was completed
by March 2012, and the examination area was enlarged sequen-
tially around Fukushima city after May 2012. Diagnostic criteriaand protocol were introduced and evaluated under an external
committee of thyroid specialists in cooperation with associated
academic societies. These criteria was developed in response to
the need for precision management, evaluation of diagnosis by
thyroid ultrasound, and a secondary examination. Most images
were considered within a normal range, but examples of minute
node and benign ﬁndings (e.g., cysts) existed. Standardization of
the diagnostic imaging and observation processes was also
attained [28]. Approximately 0.5% of those screened required a
detailed secondary examination, which included a detailed
ultrasound examination, blood test, urinalysis, and cytological
diagnosis (Table 1). Although technological changes such as
improvements in ultrasound diagnostic instrument that detects
small changes (such as cysts and nodules) at a ratio of high
frequency have occurred, it is necessary to pay close attention to
changes using qualitative diagnosis over time. Hereafter, medical
examinations inside and outside the prefecture have been
organized using introduction and accuracy control of these
criteria, and thyroidal examination will continue for all candi-
dates over the next 2 years. Even if the ﬁxed group of approxi-
mately 360,000 people attains an age of 420 years, medical
examination will continue to be conducted every 5 years, and the
success or failure of the long-term follow-up survey is important.
In addition, survivors of the atomic bomb in Hiroshima and
Nagasaki were mainly exposed to external radiation, which led
to an outbreak of the solid tumors after a 10-year latency period.
Therefore, we re-evaluated the statistical differences between
cancer risk by radiation exposure, which was higher than 100
(4200) mSv [29]. Furthermore, Furukawa et al. recently reported
a signiﬁcant dose-response relationship between externally
exposed organ-dose and thyroid cancer risk estimation at the
level of more than 150–200mSv [30]. Despite of low dose
radiation exposure on thyroid glands, efforts toward under-
standing the public concern in the risk of external and internal
radiation-associated thyroid cancer in Fukushima, especially in
children, should be further performed.
In contrast to the initial increase of childhood thyroid cancer
4–5 years after the accident in Chernobyl, which was mainly
caused by internal exposure to radioactive iodine, the precedent
thyroid examination currently conducted at Fukushima also
checks for underlying disease in the thyroid gland by a sophis-
ticated screening before evaluating the effect of the nuclear
power plant accident. Furthermore, the prevalence of disease is
expected to rise due to the implementation of routine thyroid
ultrasound screening in Fukushima, but will also clarify the
health effects of radiation, protect the health of residents in the
long-term, and continue careful correspondence. In particular,
countermeasures based on scientiﬁc evidence and the interna-
tional peer-reviewed processes [16], which utilize the lessons of
the Chernobyl accident, are required, and the simultaneous
development of mental care facilities in Fukushima are needed
to meet the social and psychological needs of the residents.4. Summary
The risk of radiation-associated thyroid cancer in Fukushima
is quite different from that of Chernobyl at the standpoint of
the level of thyroid dose exposed by the accident. However,
we have learned an importance of initial countermeasures
Table 1 – Results of thyroid examinations conducted by the Fukushima Medical University.
Determination Basis of determination Number of people Proportion (%)
A
(A1) No nodules or cysts 24,468 64.2
(A2) Nodules smaller than 5.0 mm and/or cysts smaller than 20 mm 13,460 35.3
B Nodules larger than 5.1 mm and/or cysts larger than 20.1 mm 186n 0.5
C Secondary examination required immediately due to state of thyroid gland,
involvement of regional lymph nodes, etc.
0 0
Total number of people examined by FMU 38,114
Explanation of determinations: For A1 and A2, a wait-and-see approach can be taken until the time of the next examination (FY2014 or
thereafter). For B and C, a secondary examination is required. (The related individuals are notiﬁed of the time and place of the examination
and then examined).
n There were cases where both nodules and cysts were found.
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before exposure to radioactive iodine released after an unex-
pected nuclear disaster should be made to increase public
safety and avoid unnecessary fear for radioactive iodines
released. Administration would prevent the stochastic effect
of low-dose, internal exposure of radioactive iodine after a
nuclear disaster and the potential increased risk of thyroid
cancer among children. Thus, it is necessary to establish a
system for long-term follow-up of all children in Fukushima
in order not only to overcome a lack of or uncertainty of
initial internal thyroid dose estimation but also to keep their
physical and mental health in calm and peace for a long time.
There were several lessons to be learned after the Fukush-
ima nuclear power plant disaster, although it is perhaps too
early to understand them all. In particular, re-examination of
the evacuation preparation area, pre-distribution of stable
iodine tablets, correspondence with residents after the acci-
dent, re-examination of public risk communication, and the
development of an optimal guideline for revival and restora-
tion after a large accident are necessary. Fortunately, there
were no victims of acute radiation syndrome in Fukushima,
and hypothyroidism resulting from deterministic effects is
unlikely.
Finally, debate and contradictory reporting about the
management of papillary microcarcinoma of the thyroid with
a diameter o1.0 cm exists for those who are diagnosed with
subclinical cancer in childhood and adulthood [31–33]. Care-
ful analysis of thyroid ultrasound data that takes into
account not only potential screening bias and exaggerated
incidence rates of thyroid disease [34], but also the treatment
strategies and outcomes is required [35].Conﬂicts of interest
The authors have no conﬂicts of interest.
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